A test for mutation theory of cancer: carcinogenesis by misrepair of DNA damaged by 4-nitroquinoline 1-oxide. by Kondo, S.
Br. J. Cancer (1977) 35, 595
A TEST FOR MUTATION THEORY OF CANCER:
CARCINOGENESIS BY MISREPAIR OF DNA DAMAGED
BY 4-NITROQUINOLINE 1-OXIDE
S. KONDO
From the Department ofFundamental Radiology, Faculty of 7Medicine,
Osaka University, Kita-ku, Osaka 530, Japan
Received 27 August 1976 Accepted 8 December 1976
Summary.-Evidence for a mutation theory of cancer is presented by reviewing
the experimental work on 4-nitroquinoline 1-oxide (4NQO) carcinogenesis. 4NQO
almost completely mimics u.v. light and produces 4NQO-purine adducts on DNA.
When 4NQO-treated cells are held in liquid medium under appropriate conditions,
the 4NQO adducts disappear from DNA, in parallel to decrease of premutational
damage in Escherichia coli, or pretransformational damage in cultured mouse cells.
Post-treatment with caffeine greatly diminishes the yields by 4NQO of mutants in
E. coli, malignant transformants in cultured mouse cells and tumour nodules in
the lung of mice. Potentially tumourigenized stem cells in the lung remain sensitive
to selective killing by caffeine for at least 5 days after 4NQO treatment, in spite of
their DNA being apparently replicated, an indication that carcinogen-damaged
DNA in the stem cell can be transmitted to its successive daughter stem cells for
many generations. This peculiar characteristic is discussed as a possible lead
to the crux of the mutation theory of cancer in vivo, and a model for carcinogenesis
is proposed.
THAT CANCER arises from mutations
in somatic cells has long been a popular
theory (Bauer, 1928; Boveri, 1929; Burnet,
1957) but it has seldom been subjected
to rigorous experimental tests. On the
other hand, the view that cancer is
caused by viruses or abnormal cellular
differentiation has been more rigorously
tested experimentally (Dulbecco, 1969;
Cold Spring Harbor Symp., 1974; Pitot
and Heidelberger, 1963; Heidelberger,
1975). This difference may simply reflect
the fact that our knowledge of animal
viruses and cellular differentiation in
mammals is more advanced than that
on mutation in mammals. In spite of
the pioneering work by Russell, Russell
and Kelly (1958) in mutagenesis in mice,
the complexity has hindered the progress
of mutation research in higher forms.
Therefore, to test the mutation theory
of cancer, knowledge of the molecular
mechanisms of mutagenesis in micro-
organisms must be applied (Witkin, 1969;
Kondo et al., 1970; Drake, 1970, Doudney,
1976). This paper gives a brief review
of experimental work (Kondo, 1976), a
discussion on the mutation theory of
cancer, and presents a model for carcino-
genesis.
Molecular nature of 4NQO damage to
DNA
4-Nitroquinoline 1-oxide (4NQO) mi-
mics u.v. radiation in its mutagenic and
lethal effects. Two u.v.-sensitive strains,
Hs3OR (uvrA-) and Hs3O(uvrB-), which
we isolated from B/r-type u.v.-resistant
strains of E. coli B, H/r3OR, and H/r30,
(arginine-requiring (arg-) with an amber-
type nonsense mutation at the argF
locus) obtained from E. M. Witkin,
showed about 30-fold higher sensitivity
than the parental strains to both 4NQO
and u.v. with respect to loss of colony-
forming ability and mutation to arg+S. KONDO
prototrophy (Kondo and Kato, 1968;
Kondo et al., 1970).
Like some other chemical carcinogens
(Miller, 1971), 4NQO reacts with DNA
only after activation by cellular meta-
bolism. 4NQO is first reduced to 4-
hydroxyaminoquinoline 1-oxide (4-
HAQO), then converted to aminoacyl-
4HAQO by reaction with an appropriate
amino acid, a reaction catalysed by
aminoacyl-tRNA synthetase in the pre-
sense of ATP. Finally, aminoacyl-
4HAQO produced 4NQO guanine or
adenine adducts (Tada and Tada, 1976;
Nagao and Sugimura, 1976), e.g. 3-(N6-
or Nl-adenyl)-4-aminoquinoline 1-oxide
(Kawazoe et al., 1975; Nagao and Sugi-
mura, 1976). Both 4NQO-guanine and
4NQO-adenine adducts are excised from
DNA of E. coli and cultured cells (mouse
and human) if they possess excision
repair ability for u.v.-induced DNA dam-
age (i.e., pyrimidine dimers). Adducts
are not excised from DNA of a uvrA-
strain of E. coli or from cells obtained
from a xeroderma pigmentosum patient,
which lack excision repair ability for
pyrimidine dimers (Ikenaga, Ichikawa-
Ryo and Kondo, 1975a; Ikenaga et al.,
1975b). However, a small fraction of
4NQO-guanine adducts are labile, and
disappear slowly from DNA in the
absence of excision repair. This could
be the cause of the X-ray-type DNA
repair synthesis which occurs in 4NQO-
treated xeroderma pigmentosum cells
(Regan and Setlow, 1973). Thus, the
majority of 4NQO damage can be re-
garded as u.v.-like. The number of
TABLE.-Comparison of Lethal Efficiency
between 4NQO and UV Damage (Ikenaga
et al., 1975a, b; Ikenaga, Takebe and
Ishii, 1977)
Organism
E. coli uvrA-
Mouse A31-714
Human cells
Number of lesions per
genome per lethal hit
4NQO 1WV
4NQO-purine pyrimidine
adducts dimers
220±55 100± 12
2-3x105 6-0x105
3 - 6 x 105 9 x 105
4NQO-purine adducts per lethal hit is
almost equal to that of pyrimidine
dimers in E. coli and cultured cells
(Table).
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FIG. 1. (A) Decrease in 4NQO-induced pre-
mutational damage (0: forarg+mutations)
(Kondo and Kato, 1968) or 4NQO-purine
adducts (V, Cii) (Ikenaga et al., 1975a)
during holding 4NQO-treated cells of E.
coli strain H/r30R in nutrient broth at
37°C. (B) Decrease in 4NQO-induced pre-
transformational damage (0) (Kakunaga,
1974) and disappearance of 4NQO-purine
adducts from DNA (A) (Ikenaga, et al.,
1975b) in 4NQO-treated mouse cells during
post-incubation in a non-DNA-replicating
state.
Excision repair of 4NQO-induced pretrans-
formational damage
4NQO-induced premutational damage
and 4NQO-purine adducts decrease in
parallel for wild-type cells of E. coli
during post-4NQO incubation in nutrient
broth at 37TC (Fig. 1). In a subclone,
A31, of BALB/3T3 (Kakunaga, 1974) the
yield of transformed cells also diminished
with time of holding the 4NQO-treated
cells under non-DNA-replicating condi-
tions (contact inhibition), in reasonable
agreement with the disappearance rate
of 4NQO-purine adducts from lDNA ob-
served by Ikenaga et al. (1975b) (Fig. 1).
From these results and others (Kakunaga,
1973; Ikenaga et al., 1975a, b; Kondo,
1976) we conclude that excision of 4NQO-
purine adducts from DNA occurs at
a rate similar to the rate of decrease
of 4NQO-induced biological damage, i.e.,
mutation in E. coli or transformation in
mouse cells. In addition, we conclude
that excision repair in E. coli and mouse
cells is error-free for 4NQO-purine adducts
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and 4NQO adducts are the major cause
of mutation and transformation.
Evidence for misrepair carcinogenesis
In E. coli, a second type of repair
exists (Setlow and Setlow, 1972) which
is completely lost in recA- strains. This
strain is immutable by u.v., 4NQO, and
various other mutagens (Witkin, 1969;
Kondo et al., 1970). E. coli strains
defective at the gene lexA (exrA) are
barely mutable by u.v. though they are
not as sensitive to killing by u.v. as
recA- strains (Witkin, 1969, 1976). Post-
replication repair is a branched process,
with an error-prone branch dependent
on the lexA gene product, and an error-
free branch, which deals with defects in
daughter strands produced by inhibition
of replication opposite the pyrimidine
dimers (or 4NQO-purine adducts) in the
template strands (Witkin, 1969, 1976;
Setlow and Setlow, 1972; Kondo, 1976).
However, no lexA--equivalent clone is
available for mouse. Witkin and Far-
quharson (1969), however, demonstrated
that caffeine post-treatment of u.v.-
irradiated E. coli partially mimics the
phenotype of the lexA- strain.
As observed for u.v. mutagenesis,
post-4NQO treatment with caffeine (which
was added to agar plates) enhanced up
to an intermediate dose, but diminished
at a higher dose, the 4NQO-induced
mutation in E. coli wild type, whereas
4NQO mutagenesis in an excisionless
strain was suppressed with increasing
caffeine doses (Fig. 2). The frequency
of transformation produced by 4NQO in
mouse cells decreased with increase in
caffeine dose administered for 48 h after
4NQO treatment (Kakunaga, 1975) (Fig.
2). However, caffeine post-treatment
enhanced up to intermediate doses,
but diminished at a higher dose, the
N-acetoxy-2-fluorenylacetamide - induced
transformation in Syrian hamster cells
(Donovan and DiPaolo, 1974) (Fig. 2).
Nomura (1976) found that the average
number of tumour nodules per lung in
female mice treated with a single injection
of 4NQO (12.5 /tg/g) was decreased by
about 70% by caffeine (5 injections of
100/tg/g at 6- or 12-h intervals) ad-
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FIG. 2. Comparison of the caffeine-post-treatment effects on transformation in rodent cells, muta-
tions in E. coli and lung tumourigenesis in mice. (A) Transformed cells induced in mouse cells
(Kakunaga, 1975) and Syrian hamster cells (Donovan and DiPaolo, 1974). 4NQO-treated mouse
cells and N-acetoxy-2-fluorenylacetamide-treated hamster cells were post-treated with caffeine
at indicated doses for appropriate time before seeding on fresh plates to score transformed foci.
(B) Mutations to prototrophy (arg+) induced by 4NQO (Ichikawa-Ryo, H. and Kondo, S., un-
published). 4NQO-treated cells of E. coli strains H/r30R (wild type) and Hs3O (uvrB; excisionless)
were plated on semi-enriched agar plates containing caffeine at indicated concentrations. (C)
Lung tumours inducad in mice by a single dose of 4NQO (12-5 iug/g) (Nomura, 1976). Five
doses of caffeine (100 i'g/g each) at 6-12-h intervals were given before 4NQO (V: the last dose
12h beforehand) or after 4NQO (0: in the 0-36h; 0: in the 120-156h).
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ministered immediately or 5 days after
4NQO (Fig. 2).
From a knowledge of postreplication
repair of u.v. damage in cultured mam-
malian cells (Hanawalt and Setlow, 1975)
and of the effects of caffeine (Fujiwara
and Kondo, 1972), and by analogy with
u.v. mutagenesis in E. coli (Witkin,
1969; Doudney, 1976), we interpret the
above results by postulating that 4NQO-
induced damage to template DNA pro-
duces defects in daughter DNA strands
after replication, which are usually sealed
by normal DNA strands, but occasionally
by anomalous strands with mutated
regions. Further, the presumed error-
prone postreplication repair is inhibited
by caffeine, which results in selective
killing of cells with 4NQO-damaged DNA,
including potentially tumourigenized stem
cells. Nomura (1976) also observed that
the mortality of 4NQO-treated mice was
increased from virtually zero to about
300 by caffeine post-treatment which
was nontoxic when administered alone.
Similarly, caffeine at 50 to 200 ,ug/ml
greatly enhanced lethality of 4NQO-
treated cultured mouse cells (Kakunaga,
1975). In contrast, caffeine concentra-
tions (1000-2000 ,ug/ml) which were effec-
tive in suppressing mutations, only mar-
ginally enhanced lethalitv in 4NQO-
treated (Ichikawa-Ryo and Kondo, un-
published) and u.v.-irradiated (Witkin
and Farquharson, 1969) cells of excision-
less E. coli strains. These results indicate
that caffeine-sensitive, error-prone repair
is a minor fraction of postreplication
repair in E. coli, but a major fraction in
cultured mouse cells. Caffeine does not
suppress excision repair in mouse (Kaku-
naga, 1973) and human cells (Regan,
Trosko and Carrier, 1968), in contrast to
E. coli.
Time of fixation and expression of muta-
tions and neoplasia
Mutations are not immediately ex-
pressed after u.v. mutagenesis in E. coli
(Witkin, 1969; Doudney, 1976). Simi-
larly, 4NQO-induced premutational dam-
age in E. coli was " fixed " (being made
insensitive to suppression by caffeine
treatment) only during the first post-
4NQO DNA replication (Kondo, 1976).
4NQO-induced pretransformational dam-
age in cultured mouse cells also becomes
insensitive to suppression by caffeine
during the first DNA replication after
exposure (Kakunaga, 1975).
In E. coli, mutations to prototrophy
are dominant and their mutant character
fully appears after the first post-u.v.
(Witkin, 1969) or post-4NQO (Kondo,
1976) division, whereas recessive muta-
tions to ColBr (colicine-B-resistant muta-
tions due to change in cell membrane
character) are fully expressed only 3 to
4 cell generations after the mutation is
fixed (Ishii and Kondo, 1972). Similarly,
4NQO-induced malignant transformation
in cultured mouse cells was fully expressed
only 3 to 4 cell generations after its
fixation (Kakunaga, 1974). Harris et
al. (1969) demonstrated that malignancy
can be suppressed when malignantly
transformed cells are fused with non-
malignant cells. Thus, we conclude that
neoplastic transformation of cultured
mouse cells by 4NQO is caused byrecessive
mutations.
Discussion and concluding remarks
Carcinogenic hydrocarbons (now
known as mutagens) induce latent skin
tumours (initiation), which then develop
to gross tumours under stimulation by
croton oil or other non-carcinogenic agents
(promotion) (Berenblum, 1969). The time
between initiation and promotion has
little effect on the latent period and the
tumour yield. If initiation means pro-
duction of stem cells with an irreversibly
altered biological character, then, because
of presumed geometric proliferation, " ini-
tiated" stem cells will, sooner or later,
be either lost from or predominate in
the local, compartmented stem cell popul-
lation to which they belong, as is the
case of mutants produced in a finite
population (Crow and Kimura, 1970).
Thus, the time interval between initiation
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and promotion would be expected to
affect the latent period and the tumour
yield. This contradiction suggests that
carcinogen-" initiated " stem cells may
not always proliferate geometrically.
Cairns (1975) has proposed that a stem
cell divides into a mortal, differentiating
daughter cell and an immortal daughter
stem cell, and that the immortal daughter
cell always receives the DNA molecules
which have the older of the two parental
strands, whilst the mortal daughter col-
lects the molecules with the younger
parental strand. This idea fits the data
reported by Nomura (1976) as argued
below.
Caffeine treatment (5 injections at
6-12-h intervals over a 36-h period)
produced mortality in about 30%0 of mice
within 2 to 5 days (probably due to
intestinal death) when administered either
immediately, or 5 days after 4NQO.
Caffeine alone, 4NQO alone, or 4NQO
treatment 12 h after the end of caffeine
treatment gave negligible lethality. The
number of tumour nodules per lung in
female mice inducible by 4NQO was
reduced by about 70%0 by caffeine given
either immediately or 5 days after 4NQO,
and by about 30%0 by caffeine pretreat-
ment ending 12 h beforehand (Fig. 2).
Caffeine alone was non-tumourigenic. Thus
we conclude that the effect of caffeine
persists no more than one day after
injection and that 4NQO-treated stem
cells of intestine and lung retain almost
the same sensitivity to killing by caffeine
for at least 5 days after 4NQO. Caffeine
is effective only when it is present during
the first post-u.v. or post-4NQO DNA
replication in potentiating u.v.-induced
lethality (Rauth, 1967; Fujiwara and
Kondo, 1972) or 4NQO-induced lethal-
ity (Kakunaga, 1975) in cultured mouse
cells. This may also be the case for in
vivo stem cells. Therefore, selective kill-
ing by caffeine of potentially tumourigen-
ized cells (about 70%0) either immediately
or 5 days later could imply that about
70°U of the total stem cells in the lung,
which are in the proliferative state and
have 4NQO-damaged DNA, enter S phase
(DNA synthesis) during the 2 days after
4NQO, and yet 3 days later (i.e., 5 days
after 4NQO) about the same number
of stem cells with similarly damaged
DNA enter S phage at about the same
rate. Similarly, skin papillomas " ini-
tiated " in mice by 7,12-dimethylbenz(a)-
anthracene (DMBA) remain sensitive to
suppression by actinomycin D (which
greatly inhibits DNA synthesis (Bates et
al., 1968) and postreplication repair after
u.v. (Fujiwara, 1975) as caffeine does)
for many days after DMBA, provided
that promotion by croton oil is given
after actinomycin D (Gelboin, Klein and
Bates, 1965; Hennings and Boutwell,
1967). Actinomycin D destroys the cells
of skin treated by DMBA 34 days pre-
viously, but not those subjected to croton-
oil post-treatment 2 days before actino-
mycin D. This indicates selective killing
of cells with DMBA damage (Hennings
and Boutwell, 1967). Thus, we may
conclude that stem cells potentially tu-
mourigenized by an appropriate carcino-
gen remain sensitive to selective killing by
caffeine because of the persistence of
carcinogen-damaged DNA and in spite
of their DNA being replicated. This will
occur if the carcinogen damage in the
older of the parental DNA strands of
treated stem cells is made resistant or
inaccessible to excision repair and then
transmitted to offspring stem cells but
not to mortal, daughter cells (Fig. 3).
This kind of model may partly explain
why human peripheral lymphocytes with
" unstable " chromosomal aberrations per-
sist for some years after exposure to
ionizing radiations (Bender, 1969).
If the above modification of Cairns'
model holds true, " promotion " could
correspond to production of invasive and
proliferative mutant stem cells from stem
cells with DNA damage. This could
occur when the orderliness of an un-
changing population of stem cells in
mature animal organs is partly broken
down by abnormal differentiation, by
ageing, or by carcinogen exposure (Fig. 3).
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FIG. 3.-A model for the stem cell with persistent DNA damage to become progenitor of a mutant
(precancerous) stem cell (modified from Cairns, 1975). A stem cell (S) at the first generation
is given damage (0) to immortal ( ) and mortal (-- -) DNA strands. I assume that
DNA damage is resistant to repair in the stem cell. The damaged immortal DNA, which remains
sensitive to caffeine, is transmitted to offspring stem cells and produces daughter strands (in-
sensitive to caffeine) which are occasionally mutated (W) and transmitted to mortal daughter cells (D1, D2, ... Dn). However, some of the mutated strands may become immortal ( ) by chance, when the new daughter cell is destined to be a new stem cell (S'). Some of these
immortal mutant cells will, after lapse of time, develop to cancer or to clones of a large mutant
somatic cell population. Such newborn stem cells must arise occasionally during the creation
or development of an organ at the foetal or young stage, as a healing process for an injured organ,
after treatments with cell-division stimulants (e.g., hormone, croton oil) or when some of the
stem cells die due to external (e.g., carcinogen) or internal (e.g., ageing) causes. This model
readily explains, though yet unproved, the shortening of the development time for ear cancer
in mice with increasing u.v. doses (Blum, 1959) and for leukaemia in atomic bomb survivors with
increase in radiation doses or decreased age at time of bombing (Ichimaru and Ishimaru, 1975).
Stem cells will be newly born more frequently from damage-free stem cells than from damage- bearing ones, resulting in natural selection of fitter stem cells. The present model predicts that
foetuses or wound-healing parts in adults will rapidly lose sensitivity to suppression of tumouri-
genesis by caffeine after carcinogen exposure, if the stem cells are rapidly increasing in number
by creation of new immortal strands.
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